These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38298861)

  • 1. Magnetic Resonance Enterography Assessment of Transmural Healing with Vedolizumab in Moderate to Severe Crohn's Disease: Feasibility in the VERSIFY Phase 3 Clinical Trial.
    Rimola J; Colombel JF; Bressler B; Adsul S; Siegelman J; Cole PE; Lindner D; Danese S
    Clin Exp Gastroenterol; 2024; 17():9-23. PubMed ID: 38298861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early transmural healing and its predictors assessed by magnetic resonance enterography in patients with Crohn's disease receiving ustekinumab.
    Zhou L; Hu C; Zhang R; Qiu Y; Wang Y; Liu Z; Chen B; He Y; Zeng Z; Li X; Mao R; Chen M
    Therap Adv Gastroenterol; 2023; 16():17562848231170947. PubMed ID: 37168404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A magnetic resonance enterography index for assessing small bowel Crohn's disease activity.
    Zuo Y; Huang W; Wei J; Lan X
    Quant Imaging Med Surg; 2023 Apr; 13(4):2128-2142. PubMed ID: 37064394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG
    Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, Validation, and Evaluation of the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index From the ImageKids Study.
    Focht G; Cytter-Kuint R; Greer MC; Pratt LT; Castro DA; Church PC; Walters TD; Hyams J; Navon D; Martin de Carpi J; Ruemmele F; Russell RK; Gavish M; Griffiths AM; Turner D
    Gastroenterology; 2022 Nov; 163(5):1306-1320. PubMed ID: 35872072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of mesenteric lymph node involvement in proximal small bowel Crohn's disease.
    Maconi G; Sorin V; Kopylov U; Barzilay O; Ferretti F; Innamorati S; Tonolini M; Eliakim R; Amitai MM
    Therap Adv Gastroenterol; 2022; 15():17562848221118664. PubMed ID: 36035308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography?
    Kim KJ; Lee Y; Park SH; Kang BK; Seo N; Yang SK; Ye BD; Park SH; Kim SY; Baek S; Ha HK
    Inflamm Bowel Dis; 2015 Jan; 21(1):101-9. PubMed ID: 25358063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric measurement of terminal ileal Crohn's disease by magnetic resonance enterography: a feasibility study.
    Kumar S; Rao N; Bhagwanani A; Parry T; Hameed M; Rahman S; Fitzke HE; Holmes J; Barrow B; Bard A; Menys A; Bennett D; Mallett S; Taylor SA
    Eur Radiol; 2024 Jul; ():. PubMed ID: 39028375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bowel preparation for magnetic resonance enterography in patients with Crohn's disease: study protocol for a randomized controlled trial.
    Dai M; Zhang T; Li Q; Cui B; Xiang L; Ding X; Rong R; Bai J; Zhu J; Zhang F
    Trials; 2019 Jan; 20(1):1. PubMed ID: 30606236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT or MR Enterography to Assess Response During Vedolizumab Therapy for Small Bowel Crohn's Disease.
    Kwapisz L; Bruining DH; Inoue A; Lee YS; Edwards PK; Holmes DR; Carter RE; Siegelman J; Fletcher JG
    Crohns Colitis 360; 2022 Jan; 4(1):otac003. PubMed ID: 36777547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.
    Eder P; Katulska K; Krela-Kaźmierczak I; Stawczyk-Eder K; Klimczak K; Szymczak A; Linke K; Łykowska-Szuber L
    Abdom Imaging; 2015 Oct; 40(7):2210-8. PubMed ID: 26048698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the Mixed Use of Magnetic Resonance Enterography and Computed Tomography Enterography Adequate for Routine Periodic Follow-Up of Bowel Inflammation in Patients with Crohn's Disease?
    Ha J; Park SH; Son JH; Kang JH; Ye BD; Park SH; Kim B; Choi SH; Park SH; Yang SK
    Korean J Radiol; 2022 Jan; 23(1):30-41. PubMed ID: 34564963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of sonographic activity scores for adult terminal ileal Crohn's disease compared to magnetic resonance and histological reference standards: experience from the METRIC trial.
    Kumar S; Parry T; Mallett S; Plumb A; Bhatnagar G; Beable R; Betts M; Duncan G; Gupta A; Higginson A; Hyland R; Lapham R; Patel U; Pilcher J; Slater A; Tolan D; Zealley I; Halligan S; Taylor SA;
    Eur Radiol; 2024 Jan; 34(1):455-464. PubMed ID: 37526665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn's Disease.
    Kucharzik T; Wilkens R; D'Agostino MA; Maconi G; Le Bars M; Lahaye M; Bravatà I; Nazar M; Ni L; Ercole E; Allocca M; Machková N; de Voogd FAE; Palmela C; Vaughan R; Maaser C;
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):153-163.e12. PubMed ID: 35842121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn's Disease.
    Weinstein-Nakar I; Focht G; Church P; Walters TD; Abitbol G; Anupindi S; Berteloot L; Hulst JM; Ruemmele F; Lemberg DA; Leach ST; Cytter R; Greer ML; Griffiths AM; Turner D;
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1089-1097.e4. PubMed ID: 29501599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ileal Crohn's disease response to TNF antagonists: Validation of MR enterography for assessing response. Initial results.
    Gordic S; Bane O; Kihira S; Peti S; Hectors S; Torres J; Cho J; Colombel JF; Taouli B
    Eur J Radiol Open; 2020; 7():100217. PubMed ID: 33102636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease.
    Van Assche G; Herrmann KA; Louis E; Everett SM; Colombel JF; Rahier JF; Vanbeckevoort D; Meunier P; Tolan D; Ernst O; Rutgeerts P; Vermeire S; Aerden I; Oortwijn A; Ochsenkühn T
    J Crohns Colitis; 2013 Dec; 7(12):950-7. PubMed ID: 23411006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of magnetic resonance enterography in diagnosis and treatment follow up in Crohn's disease in children.
    Krzesiek E; Nienartowicz E; Iwańczak B
    Adv Med Sci; 2020 Mar; 65(1):214-222. PubMed ID: 32087571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of Contrast-enhanced Ultrasonography and Dynamic Contrast-enhanced MR Enterography in the Assessment of Transmural Activity and Fibrosis in Crohn's Disease.
    Wilkens R; Hagemann-Madsen RH; Peters DA; Nielsen AH; Nørager CB; Glerup H; Krogh K
    J Crohns Colitis; 2018 Jan; 12(1):48-56. PubMed ID: 28981627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.